We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Postpones eCTD Requirements for Drug Master Files by One Year
FDA Postpones eCTD Requirements for Drug Master Files by One Year
Less than a month shy of mandating electronic submissions of drug and biologic master files in the eCTD format, the FDA has decided to postpone the requirement until May 2018.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor